MedTrace Logo

Vancomycin and Cefoxitin During Pediatric Cardiopulmonary Bypass

NCT02839486 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-01-14

No results posted yet for this study

Summary

The aim of this study will be to evaluate vancomycin and cefoxitin blood levels during elective cardiopulmonary bypass (CPB) surgery in four pre-determined pediatric strata: neonates, infants, children weighting less than 40 kg and children weighting more than 40 kg.

Conditions

  • Congenital Heart Disease

Interventions

OTHER

vancomycin pharmacokinetics

vancomycin serial plasmatic and ultrafiltrate samples in order to assess plasmatic and ultrafiltrate drug concentrations

OTHER

cefoxitin pharmacokinetics

cefoxitin serial plasmatic and ultrafiltrate samples in order to assess plasmatic and ultrafiltrate drug concentrations

Sponsors & Collaborators

  • Bambino Gesù Hospital and Research Institute

    lead OTHER

Principal Investigators

  • zaccaria ricci, MD · Bambino Gesù Hospital

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2017-12-20
Completion
2019-07-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02839486 on ClinicalTrials.gov